Listed by the USPTO as THOMAS, TIMOTHY P
Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 26% of resolved cases
Thomas, Timothy P is assigned to Tech Center 1600 and Art Unit 1611. His profile records 917 resolved cases, an allowance rate of 26.2%, and an interview lift of 38.1%. The figures support a deliberate prosecution strategy centered on claim construction, prior-art distinctions, and well-prepared interviews. Direct engagement may be particularly useful when the applicant can address a specific reason for nonallowance.
The listed companies are Remedy Pharmaceuticals Inc., Danstar Ferment AG, and Vector Vitale Ip LLC. The listed firms are CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC, Davidson Kappel LLC, and DORITY & MANNING, P.A. These recurring participants offer context for the examiner's applicant and counsel mix.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17638868 | REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC DISEASE | Final Rejection | SQUARE POWER LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy26.2% of resolved applications examined by Timothy P Thomas were allowed (917 resolved cases), compared with 35.1% across Art Unit 1611 over the last five years.
This examiner's interview lift is +38.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Timothy P Thomas examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).